95 related articles for article (PubMed ID: 15319569)
1. Number of metastatic sentinel nodes as predictor of axillary involvement in patients with breast cancer.
Zavagno G; De Salvo GL; Bozza F; Scalco G; Marconato R; Valletta S; Racano C; Burelli P; Nitti D; Lise M
Breast Cancer Res Treat; 2004 Jul; 86(2):171-9. PubMed ID: 15319569
[TBL] [Abstract][Full Text] [Related]
2. Reasons for failure to identify positive sentinel nodes in breast cancer patients with significant nodal involvement.
de Kanter AY; Menke-Pluijmers MB; Henzen-Logmans SC; van Geel AN; van Eijck CJ; Wiggers T; Eggermont AM
Eur J Surg Oncol; 2006 Jun; 32(5):498-501. PubMed ID: 16580810
[TBL] [Abstract][Full Text] [Related]
3. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node.
Schrenk P; Konstantiniuk P; Wölfl S; Bogner S; Haid A; Nemes C; Jagoutz-Herzlinger M; Redtenbacher S
Br J Surg; 2005 Jun; 92(6):707-13. PubMed ID: 15810047
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node identification in breast cancer patients.
Fonti R; Limite G; Sodano A; Riccardi A; Forestieri P; De Cristofaro G; Pettinato G; Salvatore M
Radiol Med; 2002 Apr; 103(4):370-7. PubMed ID: 12107387
[TBL] [Abstract][Full Text] [Related]
5. The "Sentinel Chain": a new concept for prediction of axillary node status in breast cancer patients.
Carmon M; Olsha O; Schecter WP; Raveh D; Reinus C; Hershko DD; Beller U; Golomb E
Breast Cancer Res Treat; 2006 Jun; 97(3):323-8. PubMed ID: 16791487
[TBL] [Abstract][Full Text] [Related]
6. Staging of women with breast cancer after introduction of sentinel node guided axillary dissection.
Tvedskov TF
Dan Med J; 2012 Jul; 59(7):B4475. PubMed ID: 22759850
[TBL] [Abstract][Full Text] [Related]
7. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement.
Barranger E; Coutant C; Flahault A; Delpech Y; Darai E; Uzan S
Breast Cancer Res Treat; 2005 May; 91(2):113-9. PubMed ID: 15868438
[TBL] [Abstract][Full Text] [Related]
8. Optimized sentinel node scintigraphy in breast cancer.
Paganelli G; De Cicco C; Cremonesi M; Prisco G; Calza P; Luini A; Zucali P; Veronesi U
Q J Nucl Med; 1998 Mar; 42(1):49-53. PubMed ID: 9646645
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
10. The prevalence of axillary lymph-node metastases in patients with pure tubular carcinoma of the breast and sentinel node biopsy.
Leikola J; Heikkilä P; von Smitten K; Leidenius M
Eur J Surg Oncol; 2006 Jun; 32(5):488-91. PubMed ID: 16569494
[TBL] [Abstract][Full Text] [Related]
11. Results of a standardized protocol for sentinel node imaging in breast cancer with Tc-99m labeled nanocolloidal albumin.
Rink T; Heuser T; Fitz H; Schroth HJ; Weller E; Zippel HH
Nuklearmedizin; 2001 Jun; 40(3):80-5. PubMed ID: 11475077
[TBL] [Abstract][Full Text] [Related]
12. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph-nodes.
Veronesi U; Paganelli G; Galimberti V; Viale G; Zurrida S; Bedoni M; Costa A; de Cicco C; Geraghty JG; Luini A; Sacchini V; Veronesi P
Lancet; 1997 Jun; 349(9069):1864-7. PubMed ID: 9217757
[TBL] [Abstract][Full Text] [Related]
13. Extracapsular extension of the sentinel lymph node metastasis: a predictor of nonsentinel node tumor burden.
Stitzenberg KB; Meyer AA; Stern SL; Cance WG; Calvo BF; Klauber-DeMore N; Kim HJ; Sansbury L; Ollila DW
Ann Surg; 2003 May; 237(5):607-12; discussion 612-3. PubMed ID: 12724626
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection.
Borgstein PJ; Pijpers R; Comans EF; van Diest PJ; Boom RP; Meijer S
J Am Coll Surg; 1998 Mar; 186(3):275-83. PubMed ID: 9510258
[TBL] [Abstract][Full Text] [Related]
15. Gamma-probe-guided resection of the sentinel lymph node in breast cancer.
Crossin JA; Johnson AC; Stewart PB; Turner WW
Am Surg; 1998 Jul; 64(7):666-8; discussion 669. PubMed ID: 9655279
[TBL] [Abstract][Full Text] [Related]
16. Nonvisualization of axillary sentinel node during lymphoscintigraphy: is there a pathologic significance in breast cancer?
Brenot-Rossi I; Houvenaeghel G; Jacquemier J; Bardou VJ; Martino M; Hassan-Sebbag N; Pasquier J
J Nucl Med; 2003 Aug; 44(8):1232-7. PubMed ID: 12902412
[TBL] [Abstract][Full Text] [Related]
17. Lymphoscintigraphy and radioguided biopsy of the sentinel axillary node in breast cancer.
De Cicco C; Cremonesi M; Luini A; Bartolomei M; Grana C; Prisco G; Galimberti V; Calza P; Viale G; Veronesi U; Paganelli G
J Nucl Med; 1998 Dec; 39(12):2080-4. PubMed ID: 9867145
[TBL] [Abstract][Full Text] [Related]
18. S-classification of sentinel lymph node predicts axillary nonsentinel lymph node status in patients with breast cancer.
Fink AM; Lass H; Hartleb H; Jurecka W; Salzer H; Steiner A
Ann Surg Oncol; 2008 Mar; 15(3):848-53. PubMed ID: 18043975
[TBL] [Abstract][Full Text] [Related]
19. The role of axillary lymph node dissection in breast cancer patients with sentinel lymph node micrometastases.
Gipponi M; Canavese G; Lionetto R; Catturich A; Vecchio C; Sapino A; Friedman D; Cafiero F
Eur J Surg Oncol; 2006 Mar; 32(2):143-7. PubMed ID: 16300921
[TBL] [Abstract][Full Text] [Related]
20. Sentinel node metastasis in patients with breast carcinoma accurately predicts immunohistochemically detectable nonsentinel node metastasis.
Chu KU; Turner RR; Hansen NM; Brennan MB; Giuliano AE
Ann Surg Oncol; 1999 Dec; 6(8):756-61. PubMed ID: 10622503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]